Home

Onset sikkerhed Bliv overrasket teva sec filings Gendanne ubemandede Profeti

Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha
Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha

Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.

Teva Announces New Environmental, Social and Governance (ESG) Strategy and  Goals in 2020 Report | Business Wire
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire

Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff:  analyst | Fierce Pharma
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst | Fierce Pharma

TEVA - Short Interest - Teva Pharmaceutical Industries Ltd. (NYSE) Stock -  Short Squeeze, Borrow Rates
TEVA - Short Interest - Teva Pharmaceutical Industries Ltd. (NYSE) Stock - Short Squeeze, Borrow Rates

Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical  Industries Despite Declining Revenue and FDA Warnings - Best Stocks
Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical Industries Despite Declining Revenue and FDA Warnings - Best Stocks

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech

DEF 14A
DEF 14A

DEF 14A
DEF 14A

DEF 14A
DEF 14A

DEF 14A
DEF 14A

DEF 14A
DEF 14A

TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed  2022-05-03
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed 2022-05-03

US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical  Fin Neth 10/01/2026 3.150 Bond
US88167AAE10 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Neth 10/01/2026 3.150 Bond

Teva Pharmaceutical Industries Limited (TEVA) Company Profile & Overview -  Stock Analysis
Teva Pharmaceutical Industries Limited (TEVA) Company Profile & Overview - Stock Analysis

Form 10-K
Form 10-K

After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly  $16M | Fierce Pharma
After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M | Fierce Pharma

Assenagon Asset Management S.A. Acquires 121,768 Shares of Teva  Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat
Assenagon Asset Management S.A. Acquires 121,768 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) - MarketBeat

Teva ponies up $420M to settle with investors who said company hid  price-fixing scheme | Fierce Pharma
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma

Definitive Proxy Statement
Definitive Proxy Statement

US88163VAE92 Institutional Ownership and Shareholders - Teva Pharmaceutical  Fin Llc Bond
US88163VAE92 Institutional Ownership and Shareholders - Teva Pharmaceutical Fin Llc Bond

Teva Investor Relations on the App Store
Teva Investor Relations on the App Store

Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History
Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2012-2022) History

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock

DEF 14A
DEF 14A

DEF 14A
DEF 14A

DEF 14A
DEF 14A